Impact of Early Initiation of Eslicarbazepine Acetate on Economic Outcomes Among Patients with Focal Seizure: Results from Retrospective Database Analyses

Impact of Early Initiation of Eslicarbazepine Acetate on Economic Outcomes Among Patients with Focal Seizure: Results from Retrospective Database Analyses

Abstract Introduction This study assessed the association between early initiation of eslicarbazepine acetate (ESL) as first-line therapy (1L cohort) or as first adjunctive regimen to either levetiracetam (LEV) or lamotrigine (LTG) (add-on cohort), and healthcare resource utilization (HCRU) and char...

Full description

Bibliographic Details
Main Authors: Darshan Mehta, Matthew Davis, Andrew J. Epstein, Brian Wensel, Todd Grinnell, G. Rhys Williams
Format: Article
Language:English
Published: Adis, Springer Healthcare 2020-09-01
Series:Neurology and Therapy
Subjects:
Anti-seizure drug
Early initiation
Economic benefit
Epilepsy
Eslicarbazepine acetate
Focal seizures
Online Access:https://doi.org/10.1007/s40120-020-00211-6

Internet

https://doi.org/10.1007/s40120-020-00211-6

Similar Items